Less gelatinases is associated with apolipoprotein E accumulation in glomerulosclerosis rats

Histology and Histopathology

Volumn 27, Issue 2, 2012, Pages 249-256

  Zhou, Tian Biao ^a   Qin, Yuan Han ^a   Lei, Feng Ying ^a   Su, Li Na ^a   Zhao, Yan Jun ^a   Huang, Wei Fang ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Apolipoprotein E; Extracellular matrix; Gelatinases; Glomerulosclerosis; Matrix metalloproteinase 2; Matrix metalloproteinase 9

Indexed keywords

APOLIPOPROTEIN E; GELATINASE; GELATINASE A; GELATINASE B;

ANIMAL; ARTICLE; BIOSYNTHESIS; EXTRACELLULAR MATRIX; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION TEST; MALE; METABOLISM; PATHOLOGY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WISTAR RAT;

ANIMALS; APOLIPOPROTEINS E; EXTRACELLULAR MATRIX; GELATINASES; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS; RATTUS NORVEGICUS;

EID: 84863229736     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Abe H., Matsubara T., Arai H. and Doi T. (2011). Role of Smad1 in diabetic nephropathy: Molecular mechanisms and implications as a diagnostic marker. Histol. Histopathol. 26, 531-541.
2. Adan V.S., Javier A.M., Marisol R., Jaime G.M., Dolores U.B., Rita G.D., La Pena J.E.D., Esteban J.P. and Cruz M. (2010). Association of polymorphisms within the transforming growth factor-b1 gene with diabetic nephropathy and serum cholesterol and triglyceride concentrations. Nephrology (Carlton). 15, 644-648.
3. Amara N., Goven D., Prost F., Muloway R., Crestani B. and Boczkowski J. (2010). NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts. Thorax 65, 733-738.
4. An J., Wei Q., Liu Z., Lu K.H., Cheng X., Mills G.B. and Wang L.E. (2010). Messenger RNA expression and methylation of candidate tumor-suppressor genes and risk of ovarian cancer-a case-control analysis. Int. J. Mol. Epidemiol. Genet. 1, 1-10.
5. Belhocine M., Gernigon-Spychalowicz T., Jacob M.P., Benazzoug Y. and Exbrayat J.M. (2010). Immunoexpression of gelatinase (MMP-2 and MMP-9) in the seminal vesicles and ventral prostate of Libyan jird (Meriones libycus) during the seasonal cycle of reproduction. Histol. Histopathol. 25, 619-636.
6. Calandra S., Gherardi E., Fainaru M., Guaitani A. and Bartosek I. (1981). Secretion of lipoproteins, apolipoprotein A-I and apolipoprotein E by isolated and perfused liver of rat with experimental nephrotic syndrome. Biochim. Biophys. Acta 665, 331-338.
7. Cortes-Reynosa P., Robledo T., Macias-Silva M., Wu S.V. and Salazar E.P. (2008). Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. Matrix. Biol. 27, 220-231.
8. Danilewicz M. and Wagrowska-Danielwicz M. (2009). Morphometric and immunohistochemical insight into focal segmental glomerulosclerosis in obese and non-obese patients. Nefrologia 29, 35-41.
9. Deighan C.J., Caslake M.J., McConnell M., Boulton-Jones J.M. and Packard C.J. (2000). Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1. Kidney Int. 58, 1238-1246.
10. Diao J.S., Xia W.S., Yi C.G., Wang Y.M., Li B., Xia W., Liu B., Guo S.Z. and Sun X.D. (2011). Trichostatin A inhibits collagen synthesis and induces apoptosis in keloid fibroblasts. Arch. Dermatol. Res. 303, 573-580.
11. Duan X.H., Dong J.C. and He L.Q. (2010). Effect of Bushen Huoxue recipe on the state of extracellular matrix in glomerulosclerosis rats model. Zhongguo Zhong Xi Yi Jie He Za Zhi 30, 1197-1200.
12. Duran-Vilaregut J., Del V.J., Manich G., Camins A., Pallas M., Vilaplana J. and Pelegri C. (2011). Role of MMP-9 in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington's disease. Neuropathol. Appl. Neurobiol. 37, 525-537.
13. Farooqui T. and Farooqui A.A. (2011). Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson's disease. Parkinsons. Dis. 2011, 247467.
14. Finnson K.W., Parker W.L., Chi Y., Hoemann C.D., Goldring M.B., Antoniou J. and Philip A. (2010). Endoglin differentially regulates TGF-beta-induced Smad2/3 and Smad1/5 signalling and its expression correlates with extracellular matrix production and cellular differentiation state in human chondrocytes. Osteoarthritis Cartilage 18, 1518-1527.
15. Hakki A., Mehmet K., Fulya Y.C., Serhan T., Cetin O. and Akoglu E. (2009). Histopathological changes and tumour necrosis factor-, transforming growth factor-ß and tenascin expression in patients with primary type I membranoproliferative glomerulonephritis in remission. Nephrology (Carlton) 14, 219-226.
16. Hayashi K., Sasamura H., Ishiguro K., Sakamaki Y., Azegami T. and Itoh H. (2010). Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2. Kidney. Int. 78, 69-78.
17. Hu X. and Beeton C. (2010). Detection of functional matrix metalloproteinases by zymography. J. Vis. Exp. 8, 2445.
18. Hwang I.K., Park S.M., Kim S.Y. and Lee S.T. (2004). A proteomic approach to identify substrates of matrix metalloproteinase-14 in human plasma. Biochim. Biophys. Acta 1702, 79-87.
19. Kaouthar M., Faical J., Abdelmajid K., Basma H., Mohamed B.H., Hafedh M., Tahia B., Rchid J., Jamil H. and Ayadi H. (2009). Renal a-smooth muscle actin: A new prognostic factor for lupus nephritis. Nephrology (Carlton) 14, 499-505.
20. Lee L.Y., Wu C.M., Wang C.C., Yu J.S., Liang Y., Huang K.H., Lo C.H. and Hwang T.L. (2008). Expression of matrix metalloproteinases MMP-2 and MMP-9 in gastric cancer and their relation to claudin-4 expression. Histol. Histopathol. 23, 515-521.
21. Lin C.T., Xu Y.F., Wu J.Y. and Chan L. (1986). Immunoreactive apolipoprotein E is a widely distributed cellular protein. Immunohistochemical localization of apolipoprotein E in baboon tissues. J. Clin. Invest. 78, 947-958.
22. Lin W., Tsai W.L., Shao R.X., Wu G., Peng L.F., Barlow L.L., Chung W.J., Zhang L., Zhao H., Jang J.Y. and Chung R.T. (2010). Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner. Gastroenterology 138, 2509-2518.
23. Livak K.J. and Schmittgen T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Method. Methods 25, 402-408.
24. Lorencini M., Silva J.A., de la Hoz C.L., Carvalho H.F. and Stach-Machado D.R. (2009). Changes in MMPs and inflammatory cells in experimental gingivitis. Histol. Histopathol. 24, 157-166.
25. Madro A., Kurzepa J., Czechowska G., Slomka M., Celinski K. and Szymonik-Lesiuk S. (2009). Erythropoietin inhibits liver gelatinases during galactosamine-induced hepatic damage in rats. Pharmacol. Rep. 61, 917-923.
26. Mehan R.S., Greybeck B.J., Emmons K., Byrnes W.C. and Allen D.L. (2011). Matrix metalloproteinase-9 deficiency results in decreased fiber cross-sectional area and alters fiber type distribution in mouse hindlimb skeletal muscle. Cells Tissues Organs 194, 510-520.
27. Mukhopadhyay P., Rajesh M., Batkai S., Kashiwaya Y., Hasko G., Liaudet L., Szabo C. and Pacher P. (2009). Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am. J. Physiol. Heart. Circ. Physiol. 296, H1466-H1483.
28. Neto-Neves E.M., Dias-Junior C.A., Rizzi E., Castro M.M., Sonego F., Gerlach R.F. and Tanus-Santos J.E. (2011). Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism. Crit. Care. Med. 39, 349-356.
29. Obulesu M., Venu R. and Somashekhar R. (2011). Lipid peroxidation in Alzheimer's Disease: emphasis on metal-mediated neurotoxicity. Acta. Neurol. Scand. 124, 295-301.
30. Pal S., Chen Z., Xu X., Mikhailova M. and Steffensen B. (2010). Copurified gelatinases alter the stability and biological activities of human plasma fibronectin preparations. J. Periodontal. Res. 45, 292-295.
31. Park J.H., Park S.M., Park S.H., Cho K.H. and Lee S.T. (2008). Cleavage and functional loss of human apolipoprotein E by digestion of matrix metalloproteinase-14. Proteomics 8, 2926-2935.
32. Pastorino F., Loi M., Sapra P., Becherini P., Cilli M., Emionite L., Ribatti D., Greenberger L.M., Horak I.D. and Ponzoni M. (2010). Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor. Clin. Cancer. Res. 16, 4809-4821.
33. Qin L., Wang Y.L., Bai S.X., Ji S.H., Qiu W., Tang S. and Piao Y.S. (2003). Temporal and spatial expression of integrins and their extracellular matrix ligands at the maternal-fetal interface in the rhesus monkey during pregnancy. Biol. Reprod. 69, 563-571.
34. Raij L., Azar S. and Keane W. (1984). Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney. Int. 26, 137-143.
35. Reilly M. and Rader D.J. (2006). Apolipoprotein E and coronary disease: a puzzling paradox. PLoS. Med. 3, 258.
36. Russi G., Furci L., Leonelli M., Magistroni R., Romano N., Rivasi P. and Albertazzi A. (2009). Lipoprotein glomerulopathy treated with LDLapheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report. J. Med. Case. Reports 3, 9311.
37. Saito T. and Sho S. (1995). Lipoprotein glomerulopathy: A new aspect of lipid induced glomerular injury. Nephrology (Carlton) 1, 17-24.
38. Setz C., Brand Y., Radojevic V., Hanusek C., Mullen P.J., Levano S., Listyo A. and Bodmer D. (2011). Matrix metalloproteinases 2 and 9 in the cochlea: expression and activity after aminoglycoside exposition. Neuroscience 181, 28-39.
39. Van Hul M. and Lijnen H.R. (2011). Matrix metalloproteinase inhibition impairs murine adipose tissue development independently of leptin. Endocr. J. 58, 101-107.
40. Wang W., Liu F. and Chen N. (2007). Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts. Mediators. Inflamm. 2007, 62641.
41. Yue L. and Mazzone T. (2011). Endogenous adipocyte apolipoprotein E is colocalized with caveolin at the adipocyte plasma membrane. J. Lipid. Res. 52, 489-498.
42. Yutaka K., Atsuhito N., Chisei R.A., Ko O., Eri M., Hideoki O., Ikei K., Satoshi H. (2002). Role of transforming growth factor-'/Smad signalling pathway in enhanced production of glomerular extracellular matrix in IgA nephropathy of high-serum-IgA ddY mice. Nephrology (Carlton) 7, 151-155.
43. Zeng S., Zhou X., Tu Y., Yao M., Han Z.Q., Gao F. and Li Y.M. (2011). Long-term MMP inhibition by doxycycline exerts divergent effect on ventricular extracellular matrix deposition and systolic performance in stroke-prone spontaneously hypertensive rats. Clin. Exp. Hypertens. 33, 316-324.
44. Zhang X.M., Huang S.P. and Xu Q. (2004). Quercetin inhibits the invasion of murine melanoma B16-BL6 cells by decreasing pro-MMP-9 via the PKC pathway. Cancer Chemother. Pharmacol. 53, 82-88.
45. Zhang Y., Huang P., Jiang T., Zhao J. and Zhang N. (2010). Role of aldose reductase in TGF-beta1-induced fibronectin synthesis in human mesangial cells. Mol. Biol. Rep. 37, 2735-2742.
46. Zhou G., Dada L.A., Wu M., Kelly A., Trejo H., Zhou Q., Varga J. and Sznajder J.I. (2009). Hypoxia-induced alveolar epithelialmesenchymal transition requires mitochondrial ROS and hypoxiainducible factor 1. Am. J. Physiol. Lung. Cell. Mol. Physiol. 297, L1120-L1130.
47. Zhou T.B., Qin Y.H., Lei F.Y., Su L.N., Zhao Y.J. and Huang W.F. (2011). apoE expression in glomerulus and correlation with glomerulosclerosis induced by adriamycin in rats. Ren. Fail. 33, 348-354.